Annals of Saudi medicine · 2016
Antimicrobial resistance patterns of Pseudomonas aeruginosa in tertiary care hospitals of Makkah and Jeddah.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khan Mubashir A, Faiz Aftab
Аннотация
BACKGROUND: The clinical significance of Pseudomonas aeruginosa has greatly increased due to its ability to rapidly develop resistance to major groups of antibiotics.
OBJECTIVES: Our objective was to determine the pattern of antimicrobial resistance of P aeruginosa.
DESIGN: Prospective, descriptive study.
SETTING: Four tertiary care hospitals in Makkah and Jeddah.
METHODS: Clinical isolates of P aeruginosa were processed following standard microbiological procedures. A Microscan Walk Away system was used for the identification and antibiotic susceptibility of P aeruginosa isolates.
MAIN OUTCOME MEASURES: Percentage of resistance of P aeruginosa to antibiotics.
RESULTS: The overall drug resistance among 121 strains of P aeruginosa was low to moderate to commonly used anti-pseudomonal drugs (4.9% to 30.6%). Significantly less resistance was exhibited by piperacillin tazobactam (4.9%; P < .05) and meropenem showed significantly high resistance (30.6%; P < .05) as compared to other antibiotics, followed by ticarcillin (22.3%) and imipenem (19%), irrespective of the site of infection. The antibiotics with < 10% resistance were cefepime (8.3%), amikacin (7.4%) and piperacillin-tazobactam, which showed lowest resistance (4.9%). Although, data varied between hospitals, meropenem and ticarcillin had the highest drug resistance in all hospitals. Multidrug resistance was 10.7%.
CONCLUSION: Low-to-moderate rates of drug resistance among P aeruginosa isolates were observed. Meropenem resistance was high irrespective of the site of infection. This pattern of resistance indicates probable overuse of broad-spectrum antibiotics like carbapenems. Overuse needs to be addressed by each institution, and consideration given to regulating use of broad-spectrum antibiotics.
LIMITATIONS: Results cannot be generalized as the study did not include all tertiary hospitals in these cities.
OBJECTIVES: Our objective was to determine the pattern of antimicrobial resistance of P aeruginosa.
DESIGN: Prospective, descriptive study.
SETTING: Four tertiary care hospitals in Makkah and Jeddah.
METHODS: Clinical isolates of P aeruginosa were processed following standard microbiological procedures. A Microscan Walk Away system was used for the identification and antibiotic susceptibility of P aeruginosa isolates.
MAIN OUTCOME MEASURES: Percentage of resistance of P aeruginosa to antibiotics.
RESULTS: The overall drug resistance among 121 strains of P aeruginosa was low to moderate to commonly used anti-pseudomonal drugs (4.9% to 30.6%). Significantly less resistance was exhibited by piperacillin tazobactam (4.9%; P < .05) and meropenem showed significantly high resistance (30.6%; P < .05) as compared to other antibiotics, followed by ticarcillin (22.3%) and imipenem (19%), irrespective of the site of infection. The antibiotics with < 10% resistance were cefepime (8.3%), amikacin (7.4%) and piperacillin-tazobactam, which showed lowest resistance (4.9%). Although, data varied between hospitals, meropenem and ticarcillin had the highest drug resistance in all hospitals. Multidrug resistance was 10.7%.
CONCLUSION: Low-to-moderate rates of drug resistance among P aeruginosa isolates were observed. Meropenem resistance was high irrespective of the site of infection. This pattern of resistance indicates probable overuse of broad-spectrum antibiotics like carbapenems. Overuse needs to be addressed by each institution, and consideration given to regulating use of broad-spectrum antibiotics.
LIMITATIONS: Results cannot be generalized as the study did not include all tertiary hospitals in these cities.
Предметные рубрики MeSH
Anti-Bacterial AgentsCross InfectionDrug Resistance, Multiple, BacterialHumansMeropenemMicrobial Sensitivity TestsPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationProspective StudiesPseudomonas InfectionsPseudomonas aeruginosaRespiratory SystemSaudi ArabiaTertiary Care CentersThienamycins